Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | CA4 | P22748 | 4/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL2027808 | 0.95 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Phthalic Acid SCHEMBL31612557 | 0.95 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Phthalic Acid SCHEMBL6383303 | 0.95 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Phthalic Acid SCHEMBL1896603 | 0.93 | ALDH1A1 (0.61) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Phthalic Acid SCHEMBL31301284 | 0.93 | ALDH1A1 (0.52) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Phthalic Acid SCHEMBL27897258 | 0.91 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Benzene SCHEMBL28619236 | 0.91 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Phthalic Acid SCHEMBL28409980 | 0.89 | ALDH1A1 (0.71) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Phthalic Acid SCHEMBL105218 | 0.89 | ALDH1A1 (0.71) | ALDH1A1KDM4EHPGDCA2CA4 | |
| Phthalic Acid SCHEMBL486891 | 0.89 | ALDH1A1 (0.61) | ALDH1A1KDM4EHPGDCA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112741816-A | Novel colon drug delivery system | 江苏集萃新型药物制剂技术研究所有限公司 | 2021-05-04 | — | — | CN | disclosed |
| CN-101400358-B | Scf extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY INC | 2013-06-05 | — | — | CN | disclosed |
| CN-102172363-B | SCF extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY INC | 2013-04-24 | — | — | CN | disclosed |
| CN-102172363-A | Scf extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY INC | 2011-09-07 | — | — | CN | disclosed |
| WO-2011060944-A2 | ACTIVE PHARMACEUTICAL INGREDIENT CAPSULES AND POLYUNSATURATED FATTY ACID ESTERS | GP PHARM, S.A. (ES) | 2011-05-26 | — | — | WO | disclosed |
| CN-100486568-C | Loxoprofen sodium sustained release preparation | UNIV FUDAN (CN) | 2009-05-13 | — | — | CN | disclosed |
| CN-101400358-A | SCF extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY INC (US) | 2009-04-01 | — | — | CN | disclosed |
| CN-101132781-A | Room-temperature stable dronabinol formulations | INSYS THERAPEUTICS INC (US) | 2008-02-27 | — | — | CN | disclosed |
| CN-1901888-A | Pharmaceutical compositions comprising lercanidipine | LIFECYCLE PHARMA AS (DK) | 2007-01-24 | — | — | CN | disclosed |
| CN-1628648-A | Loxoprofen sodium sustained release preparation | UNIV FUDAN (CN) | 2005-06-22 | — | — | CN | disclosed |